Fixing Broken IDH1 in Cholangiocarcinoma: How Inhibitors Are Changing the Fight
Discover how blocking broken IDH1 with inhibitors is helping cholangiocarcinoma patients. Cholangiocarcinoma Foundation Australia is helping better equip and empower patients to respond more effectively.
IDH1-Mutated Cholangiocarcinoma: Understanding PARP Inhibitors and Clinical Trials
Explore the latest research and clinical trials involving PARP inhibitors for treating IDH1-mutated intrahepatic cholangiocarcinoma.
Michael Flannery: Life Goes On: My Journey with Cholangiocarcinoma
Michael’s Journey: Overcoming Cholangiocarcinoma with Resilience, creative persistence, Hope, and Action gave him back a normal life
Steve Holmes Patient Survivor: 14000 kilometre Cycling Circumnavigation of Australia
Cycling to Empower patients. Transform survival outcomes. Support our innovative cancer response strategies and make a real difference today.
The Checkpoint Pathway: Ipilimumab and Keytruda immunotherapy combination
Discover how the combination of Ipilimumab and Keytruda removes the brakes and disguises cancer cells use to evade the immune system, offering new hope through immunotherapy.
Understanding BRCA1 and BRCA2 in Cholangiocarcinoma
Discover how BRCA1, BRCA2, and BAP1 genes influence cholangiocarcinoma and why understanding them is crucial for effective treatment.
Fixing Broken IDH1 in Cholangiocarcinoma: How Inhibitors Are Changing the Fight
Discover how blocking broken IDH1 with inhibitors is helping cholangiocarcinoma patients. Cholangiocarcinoma Foundation Australia is helping better equip and empower patients to respond more effectively.
IDH1-Mutated Cholangiocarcinoma: Understanding PARP Inhibitors and Clinical Trials
Explore the latest research and clinical trials involving PARP inhibitors for treating IDH1-mutated intrahepatic cholangiocarcinoma.
Michael Flannery: Life Goes On: My Journey with Cholangiocarcinoma
Michael’s Journey: Overcoming Cholangiocarcinoma with Resilience, creative persistence, Hope, and Action gave him back a normal life
Steve Holmes Patient Survivor: 14000 kilometre Cycling Circumnavigation of Australia
Cycling to Empower patients. Transform survival outcomes. Support our innovative cancer response strategies and make a real difference today.
The Checkpoint Pathway: Ipilimumab and Keytruda immunotherapy combination
Discover how the combination of Ipilimumab and Keytruda removes the brakes and disguises cancer cells use to evade the immune system, offering new hope through immunotherapy.
Understanding BRCA1 and BRCA2 in Cholangiocarcinoma
Discover how BRCA1, BRCA2, and BAP1 genes influence cholangiocarcinoma and why understanding them is crucial for effective treatment.
